Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Get guidance on which passive funds to buy for retirement, focusing on cost, diversification, and long-term goals.
24,385 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
A rising stake in Instacart highlights how investment groups are pricing the shift to digital grocery. This article e...
A major healthcare-focused fund just nudged its bets into a wearable heart-monitor company. This move spotlights the ...
As rates rise, some brokers benefit from higher interest income. This piece explains how Interactive Brokers can gene...
A triple-leveraged ETF focused on semiconductors can swing wildly. This piece breaks down why the direxion daily semi...
Whales are stepping in to buy the dip as Dogecoin dips to a 14-month low. On-chain data shows a notable uptick in lar...
SpaceX's IPO spark has investors buzzing, but Warren Buffett would never chase hype without a moat and predictable ca...
Crypto markets rebound as ripple’s (xrp) potential and Solana price outlook draw attention. Key on-chain data and ins...
As year-end approaches, investors are hunting for a tech stock with durable AI-driven growth and solid cash flow. Thi...
A downtown Pittsburgh convenience store is at the center of allegations that SNAP benefits were converted to cash and...
Braiin stock plummeted this week, leaving investors wondering what’s next. This article breaks down the factors behin...
A fresh look at how large holders deploy a bitcoin giant strategy and why Coinbase finds itself among the most shorte...